Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-29 Sale | 2025-05-30 5:00 pm | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 3,932 | $35.94 | $141,316 | 36,068 (Direct) | View |
| 2025-03-21 Sale | 2025-03-24 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 10,031 | $41.23 | $413,578 | 339,769 (Indirect Direct) | View |
| 2025-03-21 Sale | 2025-03-24 5:35 pm | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 1,714 | $41.23 | $70,668 | 28,882 (Indirect Direct) | View |
| 2025-03-21 Sale | 2025-03-24 5:35 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 2,197 | $41.23 | $90,582 | 35,517 (Direct) | View |
| 2025-03-21 Sale | 2025-03-24 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,185 | $41.23 | $131,318 | 100,479 (Direct) | View |
| 2025-03-17 Sale | 2025-03-18 5:35 pm | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 3,762 | $41.8 | $157,252 | 96,880 (Direct) | View |
| 2025-03-11 Sale | 2025-03-12 7:05 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 14,435 | $42.7 | $616,349 | 309,550 (Indirect Direct) | View |
| 2025-03-11 Sale | 2025-03-12 7:05 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 3,966 | $42.67 | $169,242 | 89,664 (Direct) | View |
| 2025-03-11 Sale | 2025-03-12 7:05 pm | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 1,388 | $42.54 | $59,050 | 20,392 (Indirect Direct) | View |
| 2025-02-26 Purchase | 2025-02-28 5:35 pm | CRISPR Therapeutics AG | CRSP | Greene John Director | 7,000 | $44.85 | $313,948 | 7,000 (Direct) | View |
| 2025-02-19 Sale | 2025-02-21 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 18,360 | $55.2 | $1,013,564 | 257,235 (Indirect Direct) | View |
| 2025-02-19 Sale | 2025-02-19 5:35 pm | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 333 | $52.8 | $17,582 | 14,800 (Indirect Direct) | View |
| 2025-02-18 Sale | 2025-02-19 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 18,568 | $54.21 | $1,006,580 | 288,845 (Indirect Direct) | View |
| 2025-02-18 Sale | 2025-02-19 5:35 pm | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 11,542 | $53.67 | $619,492 | 78,705 (Direct) | View |
| 2024-12-02 Sale | 2024-12-04 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 15,000 | $55.1 | $826,565 | 267,162 (Indirect Direct) | View |
| 2024-11-11 Sale | 2024-11-13 5:35 pm | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 30,000 | $55.62 | $1,668,678 | 282,162 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2025-06-10 5:31 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Morrison Briggs Director | 0 | $0 | 31,209 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:47 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | George Simeon Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:38 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Morrison Briggs Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Rommel Christian Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Greene John Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Fardis Maria Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:30 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | High Katherine A Director | 13,000 | $0 | 13,000 (Direct) | View |
Ownership | 2025-06-06 5:20 pm | N/A 2034-12-10 | CRISPR Therapeutics AG | CRSP | Morrison Briggs Director | 0 | $0 | 26,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:45 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-05-28 Exercise | 2025-05-30 5:00 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 10,000 | $0 | 36,068 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-24 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 19,688 | $0 | 339,769 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-24 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 3,750 | $0 | 28,882 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-24 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 6,250 | $0 | 35,517 (Direct) | View |
| 2025-03-20 Exercise | 2025-03-24 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 6,250 | $0 | 100,479 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 79,167 | $0 | 79,167 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 64,166 | $0 | 96,880 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-18 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 10,000 | $0 | 96,880 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 192,500 | $0 | 192,500 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 64,166 | $0 | 64,166 (Direct) | View |
| 2025-03-14 Option Award | 2025-03-18 5:35 pm | N/A 2035-03-14 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 64,166 | $0 | 64,166 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 7:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 28,250 | $0 | 309,550 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 7:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 7,750 | $0 | 89,664 (Direct) | View |
| 2025-03-10 Exercise | 2025-03-12 7:05 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 2,834 | $0 | 20,392 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-19 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 650 | $0 | 14,800 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-19 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,250 | $0 | 288,845 (Direct) | View |
| 2025-02-16 Exercise | 2025-02-19 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 23,825 | $0 | 78,705 (Direct) | View |
| 2024-12-24 Exercise | 2024-12-27 5:35 pm | N/A 2027-05-03 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,751 | $0 | 280,913 (Direct) | View |
| 2024-12-24 Exercise | 2024-12-27 5:35 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 13,751 | $16.21 | 280,913 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary | 48,333 | $0 | 48,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Bruno Julianne Chief Operating Officer | 18,333 | $0 | 18,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Patel Naimish Chief Medical Officer | 18,333 | $0 | 18,333 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer | 455,000 | $0 | 455,000 (Direct) | View |
| 2024-10-16 Option Award | 2024-10-18 5:35 pm | N/A 2034-10-16 | CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer | 33,333 | $0 | 33,333 (Direct) | View |